Graham A. Colditz Honored with AACR Distinguished Lectureship on the Science of Cancer Health Disparities
PHILADELPHIA – The American Association for Cancer Research (AACR) has announced Graham A. Colditz, MD, DrPH, MPH, as the...
Search/Filter
Loading...
AACR, Founding Organizer and Lead Sponsor of the 9th Annual Rally for Medical Research Hill Day, to Advocate for Continued Growth in Federal Funding for NIH
More than 350 organizations join forces again this year to improve health, inspire hope, and save lives WASHINGTON, D.C....
AACR Establishes New Cancer Prevention Working Group
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the formation of its eighth and newest scientific...
Low-poverty U.S. Communities May Eliminate Cervical Cancer by 2030 but High-poverty Communities May Lag Behind
The HPV vaccine has made near-elimination of cervical cancer possible, but health care disparities may delay this milestone PHILADELPHIA...
Adoptive Transfer of Tumor-infiltrating Lymphocytes May Be Less Effective in Patients With Pretreated Metastatic Melanoma
PHILADELPHIA — Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as...
First-in-class Histone Deacetylase Inhibitor Gel Shows Promise for the Treatment of Patients with Basal Cell Carcinoma
PHILADELPHIA – Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients...
AACR Establishes New Cancer Evolution Working Group
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the formation of its seventh and newest scientific...
Healthy Lifestyle May Help Mitigate High Genetic Risk of Cancer
PHILADELPHIA — Healthy lifestyle factors such as abstinence from smoking and drinking, low body mass index, and exercise correlated...
Call for Submissions: AACR June L. Biedler Prize for Cancer Journalism
Awardees to receive $5,000 cash prize PHILADELPHIA — The American Association for Cancer Research (AACR) is inviting journalists to...
Ficlatuzumab Plus Chemotherapy Shows Promise for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
PHILADELPHIA – The investigational therapeutic ficlatuzumab in combination with chemotherapy showed signs of clinical efficacy in patients with relapsed/refractory...